Cardiovascular Disease Clinical Trial
Official title:
Effects of Exercise Training on Cardiac Function and Lipid Metabolism in Mem 18-22 Year Old
The purpose of this study is to monitor the impact of exercise training on cardiac functions and lipoprotein lipids.
Status | Completed |
Enrollment | 46 |
Est. completion date | May 2013 |
Est. primary completion date | May 2013 |
Accepts healthy volunteers | No |
Gender | Male |
Age group | 18 Years to 22 Years |
Eligibility |
Inclusion Criteria: - men - age 18-25 years - body mass index (BMI) 18-25 kg/m2 - no regular exercise - no tobacco use - no current use of prescribed medications - no self-report of acute of chronic diseases Exclusion Criteria: - conditions that do not meet the inclusion criteria listed. |
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
China | No. 150 Central hospital of Chinese People's Liberation Army | Luoyang | Henan |
Lead Sponsor | Collaborator |
---|---|
No. 150 Central Hospital of the Chinese People Liberation Army |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change of cardiac function at baseline to exercise training for 3 months | baseline to 3 months | No | |
Secondary | change of lipoprotein at baseline to exercise training for 3 months | baseline to 3 months | No | |
Secondary | change of heart rate at baseline to exercise training for 3 months | baseline to 3 months | No | |
Secondary | Change of body weight at baseline to exercise training for 3 months | baseline to 3 months | No | |
Secondary | change of cardiac troponin frome baseline to exercise training for 3 months | baselin to 3 months | No | |
Secondary | Change of blood pressure from baseline to exercise training for 3 months | baseline to 3 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|